Use of monoclonal antibody-IRDye800CW bioconjugates in the resection of breast cancer

Journal of Surgical Research

Volumn 188, Issue 1, 2014, Pages 119-128

  Korb, Melissa L ^a   Hartman, Yolanda E ^a   Kovar, Joy ^b   Zinn, Kurt R ^c   Bland, Kirby I ^a   Rosenthal, Eben L ^a  

^a University of Alabama at Birmingham   (United States)

^b LI COR BIOSCIENCES   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Antibody; Breast cancer; Fluorescence; Near infrared; Optical imaging

Indexed keywords

BEVACIZUMAB; CETUXIMAB; CONTRAST MEDIUM; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FLUORESCENT DYE; INTERLEUKIN 6 RECEPTOR; IRDYE 800CW N HYDROXYSUCCINIMIDE ESTER; IRDYE800CW; MONOCLONAL ANTIBODY; PANITUMUMAB; TOCILIZUMAB; TRASTUZUMAB; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL IMAGING SYSTEM; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BREAST CANCER; CANCER DIAGNOSIS; CANCER SURGERY; CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; FLUORESCENCE IMAGING; FOOD AND DRUG ADMINISTRATION; HISTOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIGAND BINDING; MOUSE; NEAR INFRARED FLUORESCENCE PROBE; NONHUMAN; PEARL IMPULSE SYSTEM; PRIORITY JOURNAL; SPY IMAGING SYSTEM; TISSUE DIFFERENTIATION;

ANTIBODY; BREAST CANCER; FLUORESCENCE; NEAR-INFRARED; OPTICAL IMAGING;

ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; BENZENESULFONATES; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; INDOLES; INFRARED RAYS; INTRAOPERATIVE CARE; INTRAOPERATIVE PERIOD; MICE, NUDE; OPTICAL IMAGING;

EID: 84897416081     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2013.11.1089     Document Type: Article

References (35)

1. G.H. Au, W.Y. Shih, and W.H. Shih et al. Assessing breast cancer margins ex vivo using aqueous quantum-dot-molecular probes Int J Surg Oncol 2012 2012 861257
2. M.E. Ruidiaz, S.L. Blair, A.C. Kummel, and J. Wang-Rodriguez Computerized decision support system for intraoperative analysis of margin status in breast conservation therapy ISRN Surg 2012 2012 546721
3. W. Jung, E. Kang, and S.M. Kim et al. Factors associated with re-excision after breast-conserving surgery for early-stage breast cancer J Breast Cancer 15 2012 412
4. C.C. Yu, K.C. Chiang, W.L. Kuo, S.C. Shen, Y.F. Lo, and S.C. Chen Low re-excision rate for positive margins in patients treated with ultrasound-guided breast-conserving surgery Breast 22 2013 698
5. C. Dunne, J.P. Burke, M. Morrow, and M.R. Kell Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ J Clin Oncol 27 2009 1615
6. R.G. Pleijhuis, M. Graafland, J. de Vries, J. Bart, J.S. de Jong, and G.M. van Dam Obtaining adequate surgical margins in breast-conserving therapy for patients with early-stage breast cancer: Current modalities and future directions Ann Surg Oncol 16 2009 2717
7. C.H. Heath, N.L. Deep, L. Sweeny, K.R. Zinn, and E.L. Rosenthal Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model Ann Surg Oncol 19 2012 3879
8. K.E. Day, L.N. Beck, C.H. Heath, C.C. Huang, K.R. Zinn, and E.L. Rosenthal Identification of the optimal therapeutic antibody for fluorescent imaging of cutaneous squamous cell carcinoma Cancer Biol Ther 14 2013 271
9. A.G. Terwisscha van Scheltinga, G.M. van Dam, and W.B. Nagengast et al. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies J Nucl Med 52 2011 1778
10. K.E. Day, L.N. Beck, N.L. Deep, J. Kovar, K.R. Zinn, and E.L. Rosenthal Fluorescently labeled therapeutic antibodies for detection of microscopic melanoma Laryngoscope 123 2013 2681
11. M. Kijanka, F.J. Warnders, and M. El Khattabi et al. Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery Eur J Nucl Med Mol Imaging 40 2013 1718
12. M.V. Backer, Z. Levashova, and V. Patel et al. Molecular imaging of VEGF receptors in angiogenic vasculature with single-chain VEGF-based probes Nat Med 13 2007 504
13. C.J. Anderson, and R. Ferdani Copper-64 radiopharmaceuticals for PET imaging of cancer: Advances in preclinical and clinical research Cancer Biother Radiopharm 24 2009 379
14. Z. Suo, A. Bjaamer, L. Ottestad, and J.M. Nesland Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast Ultrastruct Pathol 25 2001 349
15. P. Tang, X. Wang, and L. Schiffhauer et al. Expression patterns of ER-alpha, PR, HER-2/neu, and EGFR in different cell origin subtypes of high grade and non-high grade ductal carcinoma in situ Ann Clin Lab Sci 36 2006 137
16. I. Garcia-Tunon, M. Ricote, A. Ruiz, B. Fraile, R. Paniagua, and M. Royuela IL-6, its receptors and its relationship with bcl-2 and bax proteins in infiltrating and in situ human breast carcinoma Histopathology 47 2005 82
17. G.C. Gurtner, G.E. Jones, and P.C. Neligan et al. Intraoperative laser angiography using the SPY system: Review of the literature and recommendations for use Ann Surg Innov Res 7 2013 1
18. B.D. Kulbersh, R.D. Duncan, J.S. Magnuson, J.B. Skipper, K. Zinn, and E.L. Rosenthal Sensitivity and specificity of fluorescent immunoguided neoplasm detection in head and neck cancer xenografts Arch Otolaryngol Head Neck Surg 133 2007 511
19. J.F. Vermeulen, A.S. van Brussel, and A. Adams et al. Near-infrared fluorescence molecular imaging of ductal carcinoma in situ with CD44v6-specific antibodies in mice: A preclinical study Mol Imaging Biol 15 2013 290
20. S. Keereweer, I.M. Mol, and A.L. Vahrmeijer et al. Dual wavelength tumor targeting for detection of hypopharyngeal cancer using near-infrared optical imaging in an animal model Int J Cancer 131 2012 1633
21. H. Kim, T.R. Chaudhuri, D.J. Buchsbaum, D. Wang, and K.R. Zinn High-resolution single-photon emission computed tomography and X-ray computed tomography imaging of Tc-99m-labeled anti-DR5 antibody in breast tumor xenografts Mol Cancer Ther 6 2007 866
22. K.E. Adams, S. Ke, and S. Kwon et al. Comparison of visible and near-infrared wavelength-excitable fluorescent dyes for molecular imaging of cancer J Biomed Opt 12 2007 024017
23. E. Tanaka, H.S. Choi, H. Fujii, M.G. Bawendi, and J.V. Frangioni Image-guided oncologic surgery using invisible light: Completed pre-clinical development for sentinel lymph node mapping Ann Surg Oncol 13 2006 1671
24. M.V. Marshall, D. Draney, E.M. Sevick-Muraca, and D.M. Olive Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats Mol Imaging Biol 12 2010 583
25. K. Sano, T. Nakajima, and K. Miyazaki et al. Short PEG-linkers improve the performance of targeted, activatable monoclonal antibody-indocyanine green optical imaging probes Bioconjug Chem 24 2013 811
26. E.L. Rosenthal, B.D. Kulbersh, and R.D. Duncan et al. In vivo detection of head and neck cancer orthotopic xenografts by immunofluorescence Laryngoscope 116 2006 1636
27. J.P. Gleysteen, J.R. Newman, D. Chhieng, A. Frost, K.R. Zinn, and E.L. Rosenthal Fluorescent labeled anti-EGFR antibody for identification of regional and distant metastasis in a preclinical xenograft model Head Neck 30 2008 782
28. J.P. Gleysteen, R.D. Duncan, J.S. Magnuson, J.B. Skipper, K. Zinn, and E.L. Rosenthal Fluorescently labeled cetuximab to evaluate head and neck cancer response to treatment Cancer Biol Ther 6 2007 1181
29. K. Sano, M. Mitsunaga, T. Nakajima, P.L. Choyke, and H. Kobayashi In vivo breast cancer characterization imaging using two monoclonal antibodies activatably labeled with near infrared fluorophores Breast Cancer Res 14 2012 R61
30. E. Montagna, P. Maisonneuve, and N. Rotmensz et al. Heterogeneity of triple-negative breast cancer: Histologic subtyping to inform the outcome Clin Breast Cancer 13 2013 31
31. A.S. Patchefsky, G.F. Schwartz, and S.D. Finkelstein et al. Heterogeneity of intraductal carcinoma of the breast Cancer 63 1989 731
32. T. Ibrahim, A. Farolfi, and E. Scarpi et al. Hormonal receptor, human epidermal growth factor receptor-2, and Ki67 discordance between primary breast cancer and paired metastases: Clinical impact Oncology 84 2013 150
33. F. Kommoss, M. Colley, C.E. Hart, and W.A. Franklin In situ distribution of oncogene products and growth factor receptors in breast carcinoma: C-erbB-2 oncoprotein, EGFr, and PDGFr-beta-subunit Mol Cell Probes 4 1990 11
34. J.E. Somerville, L.A. Clarke, and J.D. Biggart c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma J Clin Pathol 45 1992 16
35. E.M. Sevick-Muraca, and B. Zhu The need for performance standards in clinical translation and adoption of fluorescence molecular imaging Med Phys 40 2013 040402